Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab as the Upfront Treatment in Patients With Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS)Javier Martin-Broto, Roberto Diaz-Beveridge, David Moura, et al.
Cancers|December 16, 2020
Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference CenterNadia Hindi, Irene Carrasco García, Alberto Sánchez-Camacho, et al.
Cancers|April 3, 2021
Erratum: Hindi, N., et al. Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center. Cancers 2020, 12, 3740Nadia Hindi, Irene Carrasco García, Alberto Sánchez-Camacho, et al.
Future Oncology (London, England)|February 11, 2025
SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcomaGregory M Cote, Sant P Chawla, George Demetri, et al.
Therapeutic Advances in Medical Oncology|January 30, 2024
Trabectedin and low-dose radiation therapy in patients with advanced leiomyosarcomaJavier Martin-Broto, Alicia Olarte-García, Ricardo Fernandéz-Rodríguez, et al.
Therapeutic Advances in Medical Oncology|January 11, 2024
Delays in diagnosis and surgery of sarcoma patients during the COVID-19 outbreak in SpainJaime Carrillo-García, Serena Lacerenza, Nadia Hindi, et al.
Cancers|October 17, 2020
Prognostic Impact of let-7e MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) StudyAntonio Fernandez-Serra, David S Moura, María Dolores Sanchez-Izquierdo, et al.
Cancer|November 12, 2024
A phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously treated with pexidartinibJayesh Desai, Andrew J Wagner, Irene Carrasco Garcia, et al.
Cancers|May 6, 2020
CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) StudyDavid S Moura, Paloma Sanchez-Bustos, Antonio Fernandez-Serra, et al.
Journal for Immunotherapy of Cancer|November 18, 2020
Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trialJavier Martin-Broto, Nadia Hindi, Giovanni Grignani, et al.
Pageof 3